biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)
Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –
biote cash
Cash and short-term investments held at the end of each period.
biote's cash was $11.17M at Jun 30, 2026. For fiscal 2025 it was $24.12M, down 38.7% from the year before. The highest annual figure on record is $89.00M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.12M | -38.7% |
| FY2024 | Dec 31, 2024 | $39.34M | -55.8% |
| FY2023 | Dec 31, 2023 | $89.00M | +12.3% |
| FY2022 | Dec 31, 2022 | $79.23M | +196.0% |
| FY2021 | Dec 31, 2021 | $26.77M | +1679071.9% |
| FY2020 | Dec 31, 2020 | $1.59K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.17M | -43.0% |
| Q1 FY2026 | Mar 31, 2026 | $5.32M | -87.2% |
| Q4 FY2025 | Dec 31, 2025 | $24.12M | -38.7% |
| Q3 FY2025 | Sep 30, 2025 | $28.05M | -26.6% |
| Q2 FY2025 | Jun 30, 2025 | $19.60M | -25.8% |
| Q1 FY2025 | Mar 31, 2025 | $41.70M | -47.1% |
| Q4 FY2024 | Dec 31, 2024 | $39.34M | -55.8% |
| Q3 FY2024 | Sep 30, 2024 | $38.23M | -55.3% |
| Q2 FY2024 | Jun 30, 2024 | $26.42M | -70.1% |
| Q1 FY2024 | Mar 31, 2024 | $78.79M | -10.1% |
| Q4 FY2023 | Dec 31, 2023 | $89.00M | +12.3% |
| Q3 FY2023 | Sep 30, 2023 | $85.58M | +10.5% |
| Q2 FY2023 | Jun 30, 2023 | $88.48M | +7.0% |
| Q1 FY2023 | Mar 31, 2023 | $87.61M | +128928.8% |
| Q4 FY2022 | Dec 31, 2022 | $79.23M | +196.0% |
| Q3 FY2022 | Sep 30, 2022 | $77.46M | +26165.3% |
| Q2 FY2022 | Jun 30, 2022 | $82.73M | +16988.8% |
| Q1 FY2022 | Mar 31, 2022 | $67.90K | -92.6% |
| Q4 FY2021 | Dec 31, 2021 | $26.77M | +1679071.9% |
| Q3 FY2021 | Sep 30, 2021 | $294.92K | +117867.2% |
| Q2 FY2021 | Jun 30, 2021 | $484.09K | – |
| Q1 FY2021 | Mar 31, 2021 | $922.48K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.59K | – |
| Q3 FY2020 | Sep 30, 2020 | $250 | – |
See a number that looks wrong?